HOLLYWOOD, FL--(Marketwire - November 11, 2010) - bioRASI, a full service, global Contract Research Organization (CRO), will be exhibiting at the 2010 AAPS Conference in New Orleans on November 14 - 18th. bioRASI will be exhibiting at booth #1305, showcasing its unique and powerful optimization strategies and solutions, designed to overcome the multifaceted challenges facing today's complex clinical development programs.
"Our Sponsors want their clinical programs optimized and we deliver. Our Program Optimization Service Branch has emerged as the most unique and powerful organization in the CRO industry," said Dr. Boris Reznik, Chairman of bioRASI. "Our optimization techniques are focused on multidimensional set of criteria that includes time, costs, service level, acceptance and, of course, quality."
The Program Optimization Service Branch consists of scientists with business strengths and of business people with scientific strengths. Everybody involved is committed to a deep and fundamental understanding of the "Lab" sciences, preclinical and IND enablement processes and fully equipped with the Phase I through Phase III programs optimization techniques.
"In addition, our understanding of and capacity to navigate the peculiarities of different regulatory jurisdictions coupled with our longstanding relationships with well-respected opinion leaders, Principal Investigators, clinical sites are what drive bioRASI's ability to deliver global trial excellence," Dr. Reznik continued.
bioRASI is a Full Service Global CRO specializing in the accelerated development of generic and novel therapeutics. This experience and expertise allow bioRASI to facilitate obtaining FDA approvals by delivering high quality regulatory and clinical strategies, solutions and services, while saving their clients critical time. bioRASI's services include program optimization, project management, regulatory, clinical, data management and analysis, compliance and audit. bioRASI leverages its unique access to the world's largest facilities and patient populations in the U.S., Europe and Asia to achieve unparalleled scientific, clinical and business results at significantly lower costs. bioRASI is headquartered in Hollywood, FL and has regional offices across the U.S. and overseas.